Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Dr. Michael Guerriere

Market Cap

556.51 Million CAD

Sector

Healthcare

Website

https://www.extendicare.com

Description

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada.

Read More

Overview

Value

44

Growth

41

Health

37

Management

37

Analyst Opinion

74

Total

47

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Price-to-earnings ratio of 8.9 is lower than the market average (19.6x)
  • Has a margin-of-safety above fair value
  • Liked by analysts
  • Has strong dividend growth
  • Has high dividend yeild

Risk Factors

  • Income is not covering expenditure and investment
  • There is a history of diluting shareholders
  • Has a high level of debt
  • Does not hold enough liquid assets to cover short term liabilities
  • High preportion of income is paid as dividend

Market Peers

EXE.TO

Key Figures

PE Ratio (TTM)

8.86

Margin Of Safety (DCF)

70.38%

Revenue Growth (5 Year Average)

3.69%

Ratings Consensus

Buy

Share Buybacks

-0.59%

Dividend Yeild (TTM)

7.72%

Valuation

Value Score

44

  • Price-to-earnings ratio of 8.9 is lower than the market average (19.6x)
  • Margin-of-safety of 70.38% is better than the market average (17.95%)
  • Estimated intrinsic-value of 11.28 CAD is higher than current price ( 6.63 CAD)
  • Free-cashflow-yeild of -3.21% is worse than the market average (4.7%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 11.3 CAD

Current Price: 6.6 CAD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

8.86x

Free Cashflow Yeild

-3.21%

PE/Earnings Growth

N/A

Price/Book

4.26x

Growth

Growth Score

41

  • Earnings growth has improved this year
  • 5 Year Average Cashflow growth of 13.39% is higher than the market average (12.35%)
  • 5 Year Average Revenue growth of 3.69% is lower than the market average (10.97%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of 6.74% is lower than the market average (14.48%)
  • Free Cashflow growth has slowed this year

Revenue Growth

3.69%

Earnings Growth

6.74%

Cashflow Growth

13.39%

Health

Health Score

37

  • Cashflow is negative
  • Has a high level of debt
  • Assets do not cover liabilities
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

1.81

Piostroski Score

8.00

Debt/Equity

5.27x

Current Assets/Liabilities

0.80x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

2.39x

Dividend

Secure Dividend Score

54

  • Dividend yeild of 7.72% is more than the market average (1.85%)
  • Dividend is likely safe
  • Dividends have shown growth over the last 5 years
  • Spending a lower percentage of their income on dividends than last 5 years
  • Long term dividend payout ratio of 174.45% is high and may limit growth
  • Payout ratio (TTM) of 63.65% is higher than the average (40%)
  • Dividend growth has been slowing recently

Dividend Yeild

7.72%

Dividend Growth

4.20%

Payout Ratio (Earnings)

63.65%

Payout Ratio (Cashflow)

-240.62%

Management

Management Score

37

  • Has issued new shares to finance growth when share price is high
  • Has returned higher dividends when earnings have risen
  • Return-on-capital-employed of 10.39% is higher than the market average (10%)
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of 10.71% is lower than the market average (15%)

Average Buybacks/Dilution

-0.59%

Recent Buybacks/Dilution

-6.72%

5 Year Price Volitility

14.24%

Return On Assets

1.21%

Return On Capital Employed

10.39%

Return On Equity

10.71%

Return On Free Cashflow

12.38%

Return On Investments

N/A

Analysts

Analyst Opinion

74

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Extendicare Inc.

Currency

CAD

Beta

1.231077

Vol Avg

132475

Ceo

Dr. Michael Guerriere

Cik

Cusip

30224T863

Exchange

Toronto Stock Exchange

Full Time Employees

23500

Industry

Medical Care Facilities

Sector

Healthcare

Ipo Date

1980-03-17

Address

3000 Steeles Ave E Suite 700

City

Markham

State

ONTARIO

Country

CA

Zip

L3R 4T9

Phone

19054705534

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies